| |
ATC |
 1 Agents affecting nervous system and sensory organs
|
|
|
2 Agents affecting individual organs
|
|
|
3 Agents affecting metabolism
|
|
|
 4 Agents affecting cellular function
|
41 Cellular function activating agents
|
42 Antineoplastics
|
421 Alkylating agents
|
422 Antimetabolites
|
423 Antibiotics
|
424 Plant extract preparations
|
4240 Plant extract preparations
|
 D01068 Vinblastine sulfate (JP17/USP)
D02197 Vincristine sulfate (JP17/USP)
D01769 Vindesine sulfate (JAN/USAN)
D01935 Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN)
D00125 Etoposide (JP17/USP/INN)
D00491 Paclitaxel (JAN/USP/INN)
D02165 Docetaxel (USP); Docetaxel hydrate (JP17)
D07866 Docetaxel (JAN/INN)
D10452 Cabazitaxel acetonate (JAN)
D02168 Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN)
D01061 Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP17)
|
L01CA01
L01CA02
L01CA03
L01CA04
L01CB01
L01CD01
L01CD02
L01CD02
L01CD04
L01CE01
L01CE02
|
429 Miscellaneous
|
43 Radioactive drugs
|
44 Allergic agents
|
49 Other agents affecting cellular function
|
|
|
5 Crude drugs and Chinese medicine formulations
|
|
|
6 Agents against pathologic organisms and parasites
|
|
|
7 Agents not mainly for therapeutic purpose
|
|
|
8 Narcotics
|
Therapeutic Category of Drugs in Japan